IVONESCIMAB
Clinical trials for IVONESCIMAB explained in plain language.
Never miss a new study
Get alerted when new IVONESCIMAB trials appear
Sign up with your email to follow new studies for IVONESCIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer: ivonescimab trial launches
Disease control Recruiting nowThis study tests a drug called ivonescimab in people with advanced clear cell kidney cancer that has spread or cannot be removed by surgery. Participants must have already tried at least one other treatment, including a type of immunotherapy. The goal is to see if ivonescimab can…
Matched conditions: IVONESCIMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New drug combo shows promise for esophageal cancer before surgery
Disease control Recruiting nowThis study is testing whether adding the drug ivonescimab (AK112) to standard chemotherapy before surgery can help shrink tumors in people with advanced esophageal cancer. About 45 adults with resectable, locally advanced esophageal squamous cell carcinoma will receive the combin…
Matched conditions: IVONESCIMAB
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 06, 2026 16:01 UTC